IN-HOSPITAL COMPLICATIONS AND OUTCOME OF PATIENTS WITH ACUTE MYOCARDIAL INFARCTION IN SULAIMANI CORONARY CARE UNIT
DOI:
https://doi.org/10.17656/jsmc.10154Keywords:
Acute myocardial infarction, In-hospital complications and mortality, Sulaimani Coronary Care UnitAbstract
Background
Complications following acute myocardial infarction started to decrease in the past three decades after development of primary percutaneous coronary intervention and thrombolytic therapy, beside many other antiplatelet medications; however complications following acute myocardial infarction still is a major concern in the developing countries.
Objectives
To detect complications and mortality that follow acute myocardial infarction during hospitalization.
Methods and study design
An observational study, consecutive patients (n=120) with the diagnosis of acute myocardial infarction admitted to the Sulaimani coronary care unit from June 2017 to February 2018 were included in this study, the in-hospital mortality and complications were recorded and analyzed.
Results
The mean age of populations in this study was 61.39±10.36 years, there were (70%) males and (30%) females, 35% of patients were smokers, 47.5% of patients had hypertension, 35% of patients had diabetes mellitus, anterior wall infarctions was present in (41.7%) of patients, while inferior wall infarction was present in (34.2%) of patients, (27.5%) of patients received thrombolytic therapy, while (54.2%) of patients received primary percutaneous coronary intervention for revascularization, 3.3% of them died during hospital stay while 53.3% of them discharged from hospital in stable condition after staying one to two days in hospital. Left ventricular dysfunction was found in (20.7%) of patients while (13.3%) develop arrhythmia and (13.3%) develop cardiogenic shock.
Conclusion
In-hospital mortality rate of acute ST segment elevation myocardial infarction in this study was 3.3% which is comparable with studies from the western countries and India, this low rate of mortality belongs to high rate of revascularizations (percutaneous coronary intervention and thrombolytic.
References
White HD, French JK, Hamer AW, et al. Frequent reocclusion of patent infarct-related arteries between 4 weeks and 1 year: effects of antiplatelet therapy. J Am Coll Cardiol 1995; 25:218–223. DOI: https://doi.org/10.1016/0735-1097(94)00331-J
The GUSTO Angiographic Investigators. The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction. N Engl J Med 1993; 329:1615–1622. DOI: https://doi.org/10.1056/NEJM199311253292204
White HD, Cross DB, Elliott JM, Norris RM, Yee TW. Long-term prognostic importance of patency of the infarct-related coronary artery after thrombolytic therapy for acute myocardial infarction. Circulation 1994; 89:61–67. DOI: https://doi.org/10.1161/01.CIR.89.1.61
The APEX AMI Investigators. Pexelizumab for acute ST-elevation myocardial infarction in patients undergoing primary percutaneous coronary intervention: a randomized controlled trial. JAMA 2007; 297:43–51. DOI: https://doi.org/10.1001/jama.297.1.43
Assali AR, Iakobishvili Z, Zafrir N, et al. Characteristics and clinical outcomes of patients with cardiogenic shock complicating acute myocardial infarction treated by emergent coronary angioplasty. Int J Cardiovasc Intervent 2005; 7:193–198. DOI: https://doi.org/10.1080/14628840500445566
Hasdai D, Topol EJ, Kilaru R, et al. Frequency, patient characteristics, and outcomes of mild-to-moderate heart failure complicating ST-segment elevation acute myocardial infarction: lessons from four international fibrinolytic therapy trials. Am Heart J 2003; 145:73–79. DOI: https://doi.org/10.1067/mhj.2003.53
Menon V, White H, LeJemtel T, Webb JG, Sleeper LA, Hochman JS. The clinical profile of patients with suspected cardiogenic shock due to predominant left ventricular failure: a report from the SHOCK Trial Registry. J Am Coll Cardiol Sep 2000; 36(3 suppl A):1071–1076 DOI: https://doi.org/10.1016/S0735-1097(00)00874-3
Tanimoto T, Imanishi T, Kitabata H, et al. Prevalence and clinical signifcance of papillary muscle infarction detected by late gadoliniumenhanced magnetic resonance imaging in patients with ST-segment elevation myocardial infarction. Circulation. 2010;122:2281–7. DOI: https://doi.org/10.1161/CIRCULATIONAHA.109.935338
Yosefy C, Beeri R, Guerrero JL, et al. Mitral regurgitation after anteroapical myocardial infarction: new mechanistic insights. Circulation. 2011;123:1529–36. DOI: https://doi.org/10.1161/CIRCULATIONAHA.110.977843
Tepe NA, Edmunds LH Jr. Operation for acute postinfarction mitral insuffciency and cardiogenic shock. J Thorac Cardiovasc Surg. 1985;89:525–30. DOI: https://doi.org/10.1016/S0022-5223(19)38756-2
Topaz O, Taylor AL. Interventricular septal rupture complicating acute myocardial infarction: from pathophysiologic features to the role of invasive and noninvasive diagnostic modalities in current management. Am J Med. 1992;93:683–8 DOI: https://doi.org/10.1016/0002-9343(92)90203-N
Lopes RD, Elliott LE, White HD, et al. Antithrombotic therapy and outcomes of patients with atrial fbrillation following primary percutaneous coronary intervention: results from the APEX-AMI trial. Eur Heart J. 2009;30:2019–28. DOI: https://doi.org/10.1093/eurheartj/ehp213
Newby KH, Pisanó E, Krucoff MW, et al. Incidence and clinical relevance of the occurrence of bundle-branch block in patients treated with thrombolytic therapy. Circulation. 1996;94:2424–8. DOI: https://doi.org/10.1161/01.CIR.94.10.2424
Imazio M, Negro A, Belli R, et al. Frequency and prognostic significance of pericarditis following acute myocardial infarction treated by primary percutaneous coronary intervention. Am J Cardiol. 2009;103:1525–9 DOI: https://doi.org/10.1016/j.amjcard.2009.01.366
Figueras J, Juncal A, Carballo J, et al. Nature and progression of pericardial effusion in patients with a frst myocardial infarction: relationship to age and free wall rupture. Am Heart J. 2002;144:251–8. DOI: https://doi.org/10.1067/mjh.2002.123840
Figueras J, Barrabés JA, Serra V, et al. Hospital outcome of moderate to severe pericardial effusion complicating ST-elevation acute myocardial infarction. Circulation. 2010;122:1902–9. DOI: https://doi.org/10.1161/CIRCULATIONAHA.109.934968
Steg AG, Goldberg RJ, Gore JM, et al. Baseline characteristics, management practices and in-hospital outcomes of patients hospitalized with acute coronary syndromes in the Global Registry of Acute Coronary Events (GRACE). Am J Cardiol. 2002;90:358e363.
The Global Use of Strategies to Open Occluded Coronary Arteries (GUSTO III) Investigators. A comparison of reteplase with alteplase for acute myocardial infarction. N Eng J Med. 1997;337:1118e1123.
The Global Use of Strategies to Open Occluded Coronary Arteries in Acute Coronary Syndromes (GUSTO IIb) Angioplasty Substudy Investigators. A clinical trial comparing primary coronary angioplasty with tissue plasminogen activator for acute myocardial infarction. N Engl J Med. 1997;336:1621e1628. DOI: https://doi.org/10.1056/NEJM199706053362301
Fox KA, Cokkinos DV, Deckers J, Keil J, Maggioni A, Steg G. A pan-European survey of acute coronary syndromes. European Network for Acute Coronary Treatment (ENACT) study. Eur Heart J. 2000;21:1440e1449 DOI: https://doi.org/10.1053/euhj.2000.2185
Hiremath JS. Future of thrombolytic therapy an Indian context. JAPI. 2011;59:49e50.
The GUSTO-I Investigators. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. N Engl J Med. 1993;329:673e682.
Capewell S, Livingston BM, Maclntyre K, et al. Trends in casefatality in 117; 718 patients admitted with acute myocardial infarction in Scotland. Eur Heart J. 2000;21:1833e1840. DOI: https://doi.org/10.1053/euhj.2000.2318
Gottwik M, Zahn R, Schiele R, et al. Differences in treatment and outcome of patients with acute myocardial infarction admitted to hospitals with compared to without departments of cardiology; results from the pooled data of the Maximal Individual Therapy in Acute Myocardial Infarction(MITRA 1þ2) Registries and the Myocardial Infarction Registry (MIR). Eur Heart J. 2001;22:1794e1801 DOI: https://doi.org/10.1053/euhj.2001.2630
Steinberg BA, Moghbeli N, Buros J. Global outcomes of STelevation myocardial infarction: comparisons’ of the enoxaparin and thrombolysis reperfusion for acute myocardial infarction treatment-thrombolysis in myocardial infarction study 25 (ExTRACT-TIMI 25) registry and trial. Ann Heart J. 2007;154:54e61. DOI: https://doi.org/10.1016/j.ahj.2007.03.047
Redfors B, Angeras O, Ramunddal T, et al. 17-year trends in incidence and prognosis of cardiogenic shock in patients with acute myocardial infarction in western Sweden. Int J Cardiol 2015; 185: 256-62. DOI: https://doi.org/10.1016/j.ijcard.2015.03.106
Awad HH, Anderson FA, Jr., Gore JM, Goodman SG, Goldberg RJ. Cardiogenic shock complicating acute coronary syndromes: insights from the Global Registry of Acute Coronary Events. Am Heart J 2012; 163: 963-71. DOI: https://doi.org/10.1016/j.ahj.2012.03.003
Garcia Aurelio M, Cohen Arazi H, Higa C, et al. Infarto agudo de miocardio con supradesnivel persistente del segmento ST. Registro multicéntrico SCAR (Síndromes Coronarios Agudos en Argentina) de la Sociedad Argentina de Cardiología. Rev Argent Cardiol 2014; 82: 259-67. DOI: https://doi.org/10.7775/rac.es.v82.i4.2169
Holmes DR, Jr., Berger PB, Hochman JS, et al. Cardiogenic shock in patients with acute ischemic syndromes with and without ST-segment elevation. Circulation 1999;100: 2067-73. DOI: https://doi.org/10.1161/01.CIR.100.20.2067
Spencer FA, Meyer TE, Gore JM, Goldberg Rj. Heterogeneity in the management and outcomes of patients with acute myocardial infarction complicated by heart failure: the National Registry of Myocardial Infarction. Circulation. 2002;105:2605e2610 DOI: https://doi.org/10.1161/01.CIR.0000017861.00991.2F
Jose V, Gupta S. Mortality and morbidity of acute ST segment elevation MI in current era. Indian Heart J. 2004;56:210e214.
Schmitt J, Duray G, Gersh BJ, Hohnloser SH. Atrial fibrillation in acute myocardial infarction: asystematic review of the incidence, clinical features and prognostic implications. Eur Heart J. 2009;30:1038–1045. [PubMed: 19109347] DOI: https://doi.org/10.1093/eurheartj/ehn579
Wong CK, White HD, Wilcox RG, Criger DA, Califf RM, Topol EJ, Ohman EM. Significance of atrial fibrillation during acute myocardial infarction, and its current management: insights from the GUSTO-III trial. Card Electrophysiol Rev. 2003; 7:201–207. [PubMed: 14739713] DOI: https://doi.org/10.1023/B:CEPR.0000012382.81986.47
GUSTO-I Investigators: An international randomized trial comparing four thrombolytic strategies for AMI. N Engl J Med 1993;329:673–682. DOI: https://doi.org/10.1056/NEJM199309023291001
Wilhelmsson C, Vedin JA, Elmfeldt D, et al. Smoking and myocardial infarction. Lancet. 1975;1:415–20. [PubMed: 48609 DOI: https://doi.org/10.1016/S0140-6736(75)91488-9
Andrikopoulos GK, Richter DJ, Dilaveris PE, et al. In-hospital mortality of habitual cigarette smokers after acute myocardial infarction; the “smoker’s paradox” in a countrywide study. Eur Heart J. 2001; 22:776–84. [PubMed: 11350110] DOI: https://doi.org/10.1053/euhj.2000.2315
Kang SH, Suh JW, Choi DJ, et al. Cigarette smoking is paradoxically associated with low mortality risk after acute myocardial infarction. Nicotine Tob Res. 2013; 15:1230–8. [PubMed: 23231825] DOI: https://doi.org/10.1093/ntr/nts248
Downloads
Published
Issue
Section
License
Copyright (c) 2018 Amanj Abubakr Khaznadar and Pishtiwan Hussain Qadir
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
This work is licensed under 